7 employees
EveliQure was founded in 2012 with headquarters in Vienna and developed for the first time a combined vaccine.
2012
$2.8M
from 2 investors over 2 rounds
Eveliqure Biotechnologies raised $2.8M on July 1, 2019
Investors: ARAX Capital Partners GmbH
Eveliqure Biotechnologies raised undisclosed on January 1, 2015
Investors: Kinled Holding Ltd